PKMYT1 and hepatocellular carcinoma: Recent studies have shown that PKMYT1 expression is increased in hepatocellular carcinoma (HCC), non‐small cell lung cancer (NSCLC), and pancreatic ductal adenocarcinoma (PDAC)[5, 38] and is associated with poor survival probability.